Metagenomi Announces Closing of Initial Public Offering - Metagenomi (NASDAQ:MGX)
EMERYVILLE, Calif., Feb. 13, 2024 (GLOBE NEWSWIRE) -- Metagenomi, Inc. (NASDAQ:MGX), a precision genetic medicines company committed to developing curative therapeutics for patients using its proprietary, comprehensive
Source: benzinga.com